Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study
Authors:
- Hoonsub SoHSHoonsub So
- Chi Hyuk OhCOChi Hyuk Oh
- Tae Jun SongTSTae Jun Song
- Hyun Woo LeeHLHyun Woo Lee
- Jun Seong HwangJHJun Seong Hwang
- Sung Woo KoSKSung Woo Ko
- Dongwook OhDODongwook Oh
- Do Hyun ParkDo Hyun Park
- Sang Soo LeeSLSang Soo Lee
- Dong-Wan SeoDSDong-Wan Seo
- Sung Koo LeeSLSung Koo Lee
- Myung-Hwan KimMKMyung-Hwan Kim
Open Access
- 1 March 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5) , 952
Abstract
Background. Radiofrequency ablation (RFA) is a palliative method known for its application in the endoscopic treatment of malignant bile duct obstruction. It may be a useful rescue method for metal stent malfunction caused by tumor ingrowth. This study aimed to examine the feasibility and safety of endoluminal RFA for occluded bilateral hilar metal stents due to tumor ingrowth in patients with malignant hilar bile duct obstruction. Methods: From March 2016 to June 2018, 11 patients with unresectable malignant hilar bile duct stricture with occluded bilateral hilar metal stents due to tumor ingrowth were enrolled. Endoluminal RFA was performed through a novel temperature-controlled catheter at a setting of 7 W power for 120 s with a target temperature of 80 °C via endoscopic retrograde cholangiopancreatography (ERCP). The patients’ demographics, clinical outcomes, and adverse events were investigated. Results: The median age was 64 (interquartile range, 54–72) years. All RFA procedures were successful. Clinical success was achieved in eight patients (72.7%). During the follow-up, eight patients (72.7%) showed stent dysfunction, and the median patency after RFA was 50 days (95% confidence interval (CI): 34–not available (NA)). All stent dysfunctions were successfully managed with ERCP. Ten patients died, and the median overall survival was 289 days (95% CI, 107–NA) from RFA to death. There was one case of mild abdominal pain after the procedure without serious adverse events. Conclusions: As a rescue therapy for occluded bilateral hilar metal stents due to tumor ingrowth, endoluminal RFA seemed to be safe and useful in selected patients.Keywords
This publication has 29 references indexed in Scilit:
- New Indications for Endoscopic Radiofrequency AblationClinical Gastroenterology and Hepatology, 2018
- Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysisGastrointestinal Endoscopy, 2018
- Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trialEndoscopy, 2018
- Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-AnalysisJournal of Vascular and Interventional Radiology, 2015
- Bilateral Metallic Stenting in Malignant Hilar ObstructionClinical Endoscopy, 2014
- Endoscopic stenting for malignant hilar biliary obstructionEuropean Journal of Gastroenterology & Hepatology, 2013
- Percutaneous Intraductal Radiofrequency Ablation for Clearance of Occluded Metal Stent in Malignant Biliary Obstruction: Feasibility and Early ResultsCardioVascular and Interventional Radiology, 2013
- Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trialGastrointestinal Endoscopy, 2009
- Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective studyGastrointestinal Endoscopy, 2003
- Symptom relief and quality of life after stenting for malignant bile duct obstruction.Gut, 1994